City
Epaper

Slow tapering combined with therapy can effectively help stop antidepressants: Study

By IANS | Updated: December 12, 2025 11:55 IST

New Delhi, Dec 12 Gradual reduction of antidepressants together with psychological support can be an effective strategy to ...

Open in App

New Delhi, Dec 12 Gradual reduction of antidepressants together with psychological support can be an effective strategy to stop medication among adults who have recovered from depression, according to a study on Friday.

Antidepressants are typically recommended to be taken for six to nine months after a first episode of moderate-to-severe depression and anxiety disorders to prevent relapse.

But there are concerns about overprescribing, long-term use, and withdrawal symptoms after discontinuation, which underscore the need for evidence-based deprescribing strategies.

To understand, researchers from the University of Verona in Italy conducted a systematic review and network meta-analysis of 76 randomised controlled trials involving 17,379 adults.

The findings, published in The Lancet Psychiatry, do not suggest that antidepressants are unnecessary or that psychotherapy alone is adequate. Instead, it highlighted that the results underscore the importance of tailoring deprescribing to each individual, with a gradual individualised tapering of antidepressants alongside structured psychological support.

"

"We encourage anyone considering coming off antidepressants to discuss the process with their doctor first to jointly find the best strategy for them," he added.

The researchers estimated that slow tapering of antidepressants plus psychological support could prevent one relapse in every five individuals compared with abrupt stopping or fast tapering (the two least effective strategies) -- offering a clinically meaningful benefit.

Continuing with reduced antidepressant doses was also found to be better than abruptly stopping and fast tapering for reducing relapse, but the evidence for this was less strong.

Notably, no significant differences in reported side effects or in the number of dropouts were observed between the deprescribing strategies.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

BusinessPassenger traffic on India’s rivers records 5-fold jump to 7.64 crore in 2024-25

EntertainmentBigg Boss 19 winner Gaurav Khanna celebrates birthday with Pranit More, Kunickaa Sadanand, Amaal Mallik, Mridul Tiwari and others

NationalPassenger traffic on India’s rivers records 5-fold jump to 7.64 crore in 2024-25

NationalKerala actress assault case: Convicts plead for leniency ahead of court’s sentencing

BusinessAI Startup Rivesa AI Reaches $1.2 Million Valuation as It Builds India's First Visual AI Engine for Business Automation

Health Realted Stories

HealthThalassemia patient groups hail introduction of National Blood Transfusion Bill in Parliament

HealthWhat Foods Help Your Body Produce and Absorb Vitamin D Better? - Try These Natural Ingredients For Strong Bones and Immunity

HealthWHO refutes US CDC's claims on vaccines and autism, reaffirms there is no link

HealthBuilding Neighbourhoods of Care for Universal Health Coverage

HealthIndia’s life-insurance sector makes a strong rebound in Nov, LIC leads